ÔçÒÒŮѸÀ×

    • <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      
    

    

      Supernus Pharmaceuticals Inc
      Supernus Pharmaceuticals Inc
      SUPN
      Market Cap$2.53B
       Close$
      
      
      
      
      Compare to Similar Companies
      P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
      Supernus Pharmaceuticals IncSupernus Pharmaceuticals Inc39.2-6%4.10.1
      $42.00
      Target Price by Analysts
      7.6% downsideSupernus Pharmaceuticals Target Price DetailsTarget Price
      $97.23
      Current Fair Value
      114% upside
      Undervalued by 114% based on the discounted cash flow analysis.
      Share Statistics
      Market cap$2.53 Billion
      Enterprise Value$2.44 Billion 
      Dividend Yield$- (-)
      Earnings per Share$1.34 
      Beta0.74
      Outstanding Shares56,024,771
      Return
      Return on Equity-
      Return on Assets-
      Return on Invested Capital-
      Valuation & Multiples
      P/E Ratio39.19
      PEG302.2
      Price to Sales4.13
      Price to Book Ratio2.52
      Enterprise Value to Revenue3.67
      Enterprise Value to EBIT39.89
      Enterprise Value to Net Income37
      Total Debt to Enterprise0.02
      Debt to Equity0.05
      Revenue Sources
      No data
      Insider Trades
      ESG Score
      No data
      About Supernus Pharmaceuticals Inc
      CEO: Jack Khattar 
      
      
      


    
      
  
      
    

    
  
      

      

    
      
  To improve your user experience we use
  cookies.
  

      

    
  
  
      
  
      

  
  

  

  
  

  
HoMEÔçÒÒŮѸÀ×